Abstract
The present study evaluates the use of thiolized chitosan conjugates (CS) in combination with two fundamental carbon nanoforms (carbon dots (CDs) and Hierarchical Porous Carbons (HPC)) for the preparation of intranasally (IN) administrated galantamine (GAL) nanoparticles (NPs). Initially, the modification of CS with L-cysteine (Cys) was performed, and the successful formation of a Cys-CS conjugates was verified via 1H-NMR, FTIR, and pXRD. The new Cys-CS conjugate showed a significant solubility enhancement in neutral and alkaline pH, improving CS’s utility as a matrix-carrier for IN drug administration. In a further step, drug-loaded NPs were prepared via solid-oil–water double emulsification, and thoroughly analyzed by SEM, DLS, FTIR and pXRD. The results showed the formation of spherical NPs with a smooth surface, while the drug was amorphously dispersed within most of the prepared NPs, with the exemption of those systems contianing the CDs. Finally, in vitro dissolution release studies revealed that the prepared NPs could prolong GAL’s release for up to 12 days. In sum, regarding the most promising system, the results of the present study clearly suggest that the preparation of NPs using both Cys-CS and CDs results in a more thermodynamically stable drug dispersion, while a zero-order release profile was achieved, which is essential to attain a stable in vivo pharmacokinetic behavior.
Funder
This project has received funding from the Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Technology (GSRT), under grant agreement No [1914].
Subject
Polymers and Plastics,General Chemistry
Reference58 articles.
1. Pharmacological evaluation of novel alzheimer’s disease therapeutics: Acetylcholinesterase inhibitors related to galanthamine;Bores;J. Pharmacol. Exp. Ther.,1996
2. Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo
3. Galantamine for dementia due to Alzheimer's disease
4. Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond
5. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of alzheimer’s disease: A systematic review and meta-analysis;Hansen;Clin. Interv. Aging,2008
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献